GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
74.11
+4.24 (6.07%)
At close: May 12, 2025, 4:00 PM
73.98
-0.13 (-0.18%)
After-hours: May 12, 2025, 7:56 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Product | 13.15B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Product Growth | 0.81% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service | 6.65B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Service Growth | 3.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Revenue (Post-Q2 2024) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Revenue (Post-Q2 2024) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Visualization Solutions (AVS) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Visualization Solutions (AVS) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patient Care Solutions (PCS) | 3.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patient Care Solutions (PCS) Growth | 0.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) | 2.54B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) Growth | 8.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 50.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -26.47% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ultrasound | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ultrasound Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Imaging EBIT (Post-Q2 2024) | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging EBIT (Post-Q2 2024) Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Visualization Solutions (AVS) EBIT | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Advanced Visualization Solutions (AVS) EBIT Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patient Care Solutions (PCS) Segment EBIT | 314.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Patient Care Solutions (PCS) Segment EBIT Growth | -11.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) Segment EBIT | 810.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceutical Diagnostics (PDx) Segment EBIT Growth | 26.56% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment EBIT | 5.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Segment EBIT Growth | -37.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Segment EBIT | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Imaging Segment EBIT Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ultrasound Segment EBIT | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Ultrasound Segment EBIT Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| USCAN | 9.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| USCAN Growth | 6.59% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA | 5.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EMEA Growth | -0.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China | 2.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -13.06% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World | 3.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of World Growth | 3.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | NaN - NaN |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | NaN - NaN |
| Products Remaining Performance Obligations (RPO) | 4.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Products Remaining Performance Obligations (RPO) Growth | -3.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services Remaining Performance Obligations (RPO) | 10.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Services Remaining Performance Obligations (RPO) Growth | 7.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Remaining Performance Obligations (RPO) | 14.88B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Remaining Performance Obligations (RPO) Growth | 3.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|